Health and Healthcare
704 Articles
ThinkstockBy any stretch of normal measurement in earnings season, Gilead Sciences Inc. (NASDAQ: GILD) should have been a rocketing stock…
ThinkstockGilead Sciences Inc. (NASDAQ: GILD) and Amgen Inc. (NASDAQ: AMGN) have both reported earnings. This is a definite difference in…
ThinkstockBiotech stocks took it on the chin during the sell-off. In fact, biotech stocks may have even led the sell-off…
Thinkstock24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. Many biotech stocks pulled back…
Amgen submitted an SEC Filing showing that, as of April 1, one of its subsidiaries and a GlaxoSmithKline subsidiary have…
Most investors buying Big Pharma stocks these days are buying them for dividends and somewhat of a defensive position against…
In a new report from RBC, its analysts say that biotech stocks trading at some of the lowest forward multiples…
courtesy of Morgan StanleyLike many of its Wall Street peers, the brutal sell-off in the biotechnology space has Morgan Stanley…
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Thursday, March 27, 2014.…
After retreating from many leading biotech and emerging pharmaceutical stocks in the previous two periods, short sellers returned in early…
For the second time in less than a month, the biotechnology sector got whacked when once again, chatter coming from…
In a new report out from Jefferies, the analysts posted a complete list of the cheapest, on a P/E basis,…
In a new research report from Deutsche Bank, the equity strategists point that the companies that are maintaining and increasing…
The pricier the stock market gets, the more important it is for investors to keep a close eye on what…
Biotech and emerging pharmaceutical stocks continue to be hot, but short sellers shied away from many of them in late…
Our top personal finance-related articles today. Your wallet will thank you later.